The estimated Net Worth of Jonathan Reisin Levin is at least $32.8 Million dollars as of 15 August 2024. Mr Levin owns over 154,545 units of GCM Grosvenor stock worth over $6,338,920 and over the last 4 years he sold GCMG stock worth over $0. In addition, he makes $26,459,911 as Pres and MD & Director at GCM Grosvenor.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Sign up
Mr Levin GCMG stock SEC Form 4 insiders trading
Mr has made over 7 trades of the GCM Grosvenor stock since 2021, according to the Form 4 filled with the SEC. Most recently he exercised 154,545 units of GCMG stock worth $1,659,813 on 15 August 2024.
The largest trade he's ever made was exercising 165,832 units of GCM Grosvenor stock on 1 March 2023 worth over $1,781,036. On average, Mr trades about 101,036 units every 158 days since 2021. As of 15 August 2024 he still owns at least 590,216 units of GCM Grosvenor stock.
You can see the complete history of Mr Levin stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Mr. Jonathan Reisin Levin biography
Jonathan Reisin Levin is the Pres, MD & Director at GCM Grosvenor.
What is the salary of Mr Levin?
As the Pres and MD & Director of GCM Grosvenor, the total compensation of Mr Levin at GCM Grosvenor is $26,459,911. There are no executives at GCM Grosvenor getting paid more.
What's Mr Levin's mailing address?
Jonathan's mailing address filed with the SEC is C/O GCM GROSVENOR INC., 900 NORTH MICHIGAN AVENUE, SUITE 1100, CHICAGO, IL, 60611.
Insiders trading at GCM Grosvenor
Over the last 4 years, insiders at GCM Grosvenor have traded over $26,190,730 worth of GCM Grosvenor stock and bought 299,102 units worth $3,143,562 . The most active insiders traders include Capital Partners Gp, L.L.C...., Frederick Pollock, and Jonathan Reisin Levin. On average, GCM Grosvenor executives and independent directors trade stock every 24 days with the average trade being worth of $1,026,422. The most recent stock trade was executed by Kathleen Patricia Sullivan on 9 September 2024, trading 5,000 units of GCMG stock currently worth $53,650.
What does GCM Grosvenor do?
Grosvenor Capital Management, L.P. is global alternative asset management solutions provider. The firm primarily provides its services to pooled investment vehicles. It also provides its services to investment companies, high net worth individuals, pension and profit sharing plans and state or municipal government entities. The firm invests in equity and alternative investment markets of the United States and internationally. The firm invests in multi-strategy, credit-focused, equity-focused, macro-focused, commodity-focused, and other specialty portfolios. It focuses in hedge fund asset classes, private equity, real estate, and/or infrastructure, credit and absolute return strategies. It also focuses in primary fund investments, secondary fund investments, and co-investments with a focus on buyout, distressed debt, mezzanine, venture capital/growth equity investments. The firm seeks to make regionally-focused investments in middle-market buyout. It prefers to invest in aerospace and defense, advanced electronics, information technology, biosciences, and advanced materials. It focuses on Ohio and the Midwest region. The firm employs fundamental and quantitative analysis. Grosvenor Capital Management, L.P. was founded in 1971 and is based in Chicago, Illinois with additional offices in North America, Asia and Europe.
What does GCM Grosvenor's logo look like?
Complete history of Mr Levin stock trades at GCM Grosvenor
GCM Grosvenor executives and stock owners
GCM Grosvenor executives and other stock owners filed with the SEC include:
-
Jonathan Reisin Levin,
Pres, MD & Director -
Frederick Emmer Pollock J.D.,
MD, Chief Investment Officer & Head of Strategic Investment Group -
Francis Osarume Idehen,
MD & COO -
Michael Jay Sacks J.D.,
Chairman & CEO -
Sandra Buchanan Hurse,
MD & Chief HR Officer -
Lilly Farahnakian J.D.,
Global Chief Compliance Officer and MD of Legal & Compliance -
Michael Jay Sacks,
Chairman & CEO -
Stacie Driebusch Selinger,
MD, Head of Investor Relations & Head of Strategy and Corp. Devel. -
Eric David Levin,
MD & CTO -
Kathleen Patricia Sullivan,
MD of Corp. Fin. and Head of Accounting & Financial Reporting -
Pamela Lyn Bentley CPA, CPA,
Chief Financial Officer -
Paul Allan Meister CPA,
MD & Vice Chairman -
Capital Partners Gp, L.L.C....,
-
Francis Osarume Idehen,
Chief Operating Officer -
Stephen Malkin,
Director -
Frederick Pollock,
Chief Investment Officer -
Francesca Cornelli,
Director -
Angela Blanton,
Director -
Sandra Hurse,
Chief HR Officer -
Blythe Masters,
Director -
Kathleen Patricia Sullivan,
Principal Accounting Officer -
Jonathan Reisin Levin,
President -
Pamela L Bentley,
Chief Financial Officer -
Samuel C Iii Scott,
Director -
Michael Jay Grosvenor Holdi...,
Chief Executive OfficerChief Executive Officer